ambroxol Report issue

Small molecule Experimental
AACT ChEMBL DrugBank Drug Central KEGG MeSH PubChem repoDB

Active Ingredient History

NOW
  • Now
Ambroxol is a drug that breaks up phlegm, used in the treatment of respiratory diseases associated with viscid or excessive mucus. Ambroxol is often administered as an active ingredient in cough syrup.   Wikipedia

Chemistry

  • SMILES: Nc1c(Br)cc(Br)cc1CN[C@@H]2CC[C@@H](O)CC2
  • InChIKey: JBDGDEWWOUBZPM-XYPYZODXSA-N
  • Mol. Mass: 378.11
  • ALogP: 3.19
  • ChEMBL Molecule:
    ambroxol  
More Chemistry

Pharmacology

Alternative names

acebrophylline | ambromucil | ambroxils | ambroxol | ambroxol acefyllinate | ambroxol hcl | ambroxol hydrochloride | ambroxol theophyllinacetate | ambroxol-theophylline-7-acetate | ambroxolum | benzyl ambroxol | bisolvon metabolite viii | bromhexine metabolite viii | bromhexine-metabolite viii | broncomnes | cyclohexanol, 4-((2-amino-3,5-dibromobenzyl)amino)- (e)- | lasolvan | n-(2-amino-3,4-dibromociclohexil)-trans-4-aminociclohexanol | n-(2-amino-3,4-dibromocyclohexyl)-trans-4-aminocyclohexanol | surfolase | trans-4-((2-amino-3,5-dibromobencil)amino)ciclohexanol | trans-4-((2-amino-3,5-dibromobenzyl)amine)cyclohexanol | trans-4-((2-amino-3,5-dibromobenzyl)amino)cyclohexanol

Organizations (21)

Research & Development (21)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (11)

Approved Indications (1)


 

Mucus

Experimental Indications - Clinical Trial Phases 1-4 (11)


 

Bronchitis (Phase 3)

Cough (Phase 2)

Gaucher Disease (Phase 2)

Healthy Volunteers (Phase 1)

Lewy Body Disease (Phase 2)

Mucus (Phase 3)

Pain (Phase 2)

Parkinson Disease (Phase 2)

Pharyngitis (Phase 3)

Respiratory Tract Diseases (Phase 3)

Vision, Ocular (Phase 1/Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 28
  • # of Trial Organizations: 21

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue